Day One Biopharmaceuticals (DAWN) has recently drawn investor attention after a stretch of mixed share performance, with gains over the past month and past 3 months contrasting with a weaker one year ...
Wondering if Fair Isaac is still worth your attention after its big run in recent years, or if the current price is a stretch for what you get? The stock last closed at US$1,463.17, with a 5.3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results